The Innovative Medicines Initiative has launched two calls worth €130 million for research proposals into topics including neurological diseases, drug screening and drug delivery.
The EU-backed public-private partnership launched the calls for proposals today. Topics include making data from IMI projects more reusable, using technology to track the effectiveness of treatments for Alzheimer’s disease, and a vaccination programme for older people.
Around half of the €130m will come from Horizon 2020, with the other half from the European Federation of Pharmaceutical Industries and Associations and IMI industry partners.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.